Functional inhibitory human leucocyte antigen class I receptors on natural killer (NK) cells in patients with chronic NK lymphocytosis

Summary. Chronic natural killer (NK) lymphocytosis is a rare disorder characterized by an indolent clinical course. Despite high NK cell numbers, many patients present with only mild clinical symptoms, and are often asymptomatic. NK cells are equipped with a range of receptors that bind human leucocyte antigen (HLA)‐class I molecules. The killer immunoglobulin‐like receptors (KIR, CD158) bind groups of HLA alleles, the CD94/NKG2 receptors bind HLA‐E, and the CD85j (ILT2, LIR‐1) receptor binds to the relatively non‐polymorphic α3 domain of HLA molecules. Inhibitory HLA class I receptors silence NK cells against cells expressing normal levels of HLA class I. Analysis of NK cells in six patients with chronic NK lymphocytosis revealed a high level of the inhibitory CD94/NKG2A receptor on all NK cells. In four patients, KIR were absent, in one patient a single KIR was expressed in the absence of self‐ligand, and in one patient CD85j and multiple KIR were expressed. Cytotoxicity assays demonstrated that all HLA class I receptors were functional. The ability of monoclonal antibodies to block the receptors and allow killing of autologous target cells established that both receptor and ligand expression were adequate for inhibitory function. We propose that the silent behaviour of NK cells in patients with chronic NK lymphocytosis is due to effective inhibitory HLA class I receptors.

[1]  F. Jotereau,et al.  Expression of CD94/NKG2-A on Human T Lymphocytes Is Induced by IL-12: Implications for Adoptive Immunotherapy1 , 2002, The Journal of Immunology.

[2]  L. Zitvogel,et al.  Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk. , 2002, European cytokine network.

[3]  D. Margulies,et al.  Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. , 2002, Annual review of immunology.

[4]  M. Caligiuri,et al.  The biology of human natural killer-cell subsets. , 2001, Trends in immunology.

[5]  K. Oshimi,et al.  Differentiation stage of natural killer cell‐lineage lymphoproliferative disorders based on phenotypic analysis , 2001, British journal of haematology.

[6]  Angel Porgador,et al.  Recognition of viral hemagglutinins by NKp44 but not by NKp30 , 2001, European journal of immunology.

[7]  J. Miller,et al.  Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. , 2001, Blood.

[8]  L. Moretta,et al.  New nomenclature for MHC receptors , 2001, Nature Immunology.

[9]  L. Lanier,et al.  Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors. , 2001, International immunology.

[10]  C. Sutherland,et al.  The UL16‐binding proteins, a novel family of MHC class I‐related ligands for NKG2D, activate natural killer cell functions , 2001, Immunological reviews.

[11]  R. Biassoni,et al.  Human natural killer cell receptors and co‐receptors , 2001, Immunological reviews.

[12]  William H. Carr,et al.  Different NK Cell Surface Phenotypes Defined by the DX9 Antibody Are Due to KIR3DL1 Gene Polymorphism1 , 2001, The Journal of Immunology.

[13]  Angel Porgador,et al.  Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells , 2001, Nature.

[14]  A. Tefferi,et al.  Natural Killer Cells and the Syndrome of Chronic Natural Killer Cell Lymphocytosis , 2001, Leukemia & lymphoma.

[15]  R. Biassoni,et al.  Identification of NKp80, a novel triggering molecule expressed by human NK cells , 2001, European journal of immunology.

[16]  T. Loughran,et al.  T cell and NK cell lymphoproliferative disorders. , 2001, Hematology. American Society of Hematology. Education Program.

[17]  L. Quintanilla‐Martinez,et al.  Aggressive NK cell lymphomas: insights into the spectrum of NK cell derived malignancies , 2000, Histopathology.

[18]  M. Colonna,et al.  Natural killer‐type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T‐cell type , 2000, British journal of haematology.

[19]  Y. Tokura,et al.  Disordered expression of inhibitory receptors on the NK1‐type natural killer (NK) leukaemic cells from patients with hypersensitivity to mosquito bites , 2000, Clinical and Experimental Immunology.

[20]  C. Witt,et al.  Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. , 1999, Transplantation.

[21]  T. Loughran,et al.  Current concepts: large granular lymphocyte leukemia. , 1999, Blood reviews.

[22]  H. Warren Using carboxyfluorescein diacetate succinimidyl ester to monitor human NK cell division: Analysis of the effect of activating and inhibitory class I MHC receptors , 1999, Immunology and cell biology.

[23]  P. Bjorkman,et al.  The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. , 1999, Immunity.

[24]  R. Phyliky,et al.  A long‐term study of patients with chronic natural killer cell lymphocytosis , 1999, British journal of haematology.

[25]  A Steinle,et al.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.

[26]  K. Akashi,et al.  Interferon-gamma prevents apoptosis in Epstein-Barr virus-infected natural killer cell leukemia in an autocrine fashion. , 1999, Blood.

[27]  J. Coligan,et al.  Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. , 1999, Journal of immunology.

[28]  R. Bellomo,et al.  Transforming growth factor‐β‐induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes , 1999, European journal of immunology.

[29]  M. Colonna,et al.  A novel family of inhibitory receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. , 1999, Current topics in microbiology and immunology.

[30]  D. Cosman,et al.  Interactions of LIRs, a family of immunoreceptors expressed in myeloid and lymphoid cells, with viral and cellular MHC class I antigens. , 1999, Current topics in microbiology and immunology.

[31]  M. Caligiuri,et al.  Flt3 Ligand Promotes the Generation of a Distinct CD34+Human Natural Killer Cell Progenitor That Responds to Interleukin-15 , 1998 .

[32]  J. Coligan,et al.  Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated Lysis , 1998, The Journal of experimental medicine.

[33]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[34]  R. Bellomo,et al.  HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Caligiuri,et al.  Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. , 1998, Blood.

[36]  P Parham,et al.  Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. , 1997, Immunity.

[37]  P Parham,et al.  Human diversity in killer cell inhibitory receptor genes. , 1997, Immunity.

[38]  R. Nash,et al.  Spontaneous resolution of p58/EB6 antigen restricted NK‐type lymphoproliferative disease of granular lymphocytes: role of Epstein Barr virus infection , 1997, British journal of haematology.

[39]  S. Foung,et al.  Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients with CD3- (natural killer) lymphoproliferative disease of granular lymphocytes. , 1997, Blood.

[40]  K. Oshimi,et al.  The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. , 1997, Blood.

[41]  F Rodeghiero,et al.  Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. , 1997, Blood.

[42]  H. Kanegane,et al.  Chronic persistent Epstein‐Barr virus infection of natural killer cells and B cells associated with granular lymphocytes expansion , 1996, British journal of haematology.

[43]  Eric O Long,et al.  Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. , 1996, Immunology today.

[44]  P. Pontisso,et al.  Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes. , 1995, Leukemia.

[45]  L. Lanier,et al.  Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. , 1995, Journal of immunology.

[46]  H. Warren,et al.  Differential expression of CD45R0 on natural killer (NK) cells in patients with an NK lymphocytosis , 1994, Immunology and cell biology.

[47]  E. Ciccone,et al.  Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes. , 1993, Blood.

[48]  H. Warren,et al.  Human natural killer (NK) cells: Requirements for cell proliferation and expansion of phenotypically novel subpopulations , 1993, Immunology and cell biology.